Treatment Preferences in Germany Differ Among Apheresis Patients with Severe Hypercholesterolemia

from PharmacoEconomics at http://bit.ly/2nqbHmc on January 31, 2018 at 07:21PM Abstract Background Severe hypercholesterolemia is a major risk factor of death in patients with coronary heart disease. New adjunctive drug therapies (proprotein convertase subtilisin/kexin type 9 [PCSK9] inhibitors) have gained approval in Europe and the USA. Objective In this empirical study, we documented preferences regarding […]

A framework for testing the equality between the health concentration curve and the 45-degree line

from Health Economics at http://bit.ly/2rT0nDU on January 31, 2018 at 09:01AM Summary The health concentration curve is the standard graphical tool to depict socioeconomic health inequality in the literature on health inequality. This paper shows that testing for the absence of socioeconomic health inequality is equivalent to testing if the conditional expectation of health on […]

Amazon, JPMorgan Chase & Co, and Berkshire Hathaway Partner on U.S. Healthcare

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2nmZFd5 on January 31, 2018 at 12:31AM Three companies have recently partnered with the aim of improving employee satisfaction and reducing costs for their U.S. employees healthcare. Amazon, Berkshire Hathaway, and JPMorgan Chase & Co recently announced their partnership and say their initial focus will be on technology […]

What if Amazon ran hospitals?

from Healthcare Economist at http://bit.ly/2DRrc0D on January 30, 2018 at 09:01PM Interesting thought experiment, especially in light of the recent Amazon+JP Morgan+Berkshire Hathaway collaboration.   The N.Y. Times states that: Planning for the new company is being led by Marvelle Sullivan Berchtold, a JPMorgan managing director who was previously head of the Swiss drugmaker Novartis’s […]

Spotlight on 2017

from RAND Research Topic: Health and Health Care at http://bit.ly/2Ep79Ux on January 30, 2018 at 08:10PM RAND Europe’s annual review, Spotlight on 2017, features some of the objective research and analysis we do to help policy and decision makers keep pace with an ever-changing world.